S E Epstein

Author PubWeight™ 435.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004 6.49
2 Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004 6.43
3 Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990 5.91
4 Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994 4.94
5 Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise. Circ Res 1966 3.95
6 Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med 1991 3.80
7 Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996 3.40
8 Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation 1973 3.31
9 Colitis cystica profunda. Am J Clin Pathol 1966 3.28
10 Sudden death in young athletes. Circulation 1980 3.05
11 Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease. N Engl J Med 1977 2.94
12 Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med 1987 2.88
13 Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. J Am Coll Cardiol 2000 2.61
14 Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation 1989 2.56
15 "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988 2.53
16 A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989 2.45
17 Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 1981 2.37
18 Causes of sudden death in competitive athletes. J Am Coll Cardiol 1986 2.31
19 Comparative left ventricular dimensions in trained athletes. Ann Intern Med 1975 2.27
20 Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 2001 2.22
21 Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986 2.18
22 Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med 1987 2.18
23 Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976 2.08
24 Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 2000 2.05
25 Impaired left ventricular diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography. Circulation 1981 2.00
26 Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994 1.98
27 Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis. N Engl J Med 1973 1.96
28 Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation 1975 1.96
29 Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol 1981 1.89
30 Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris. Circulation 1971 1.89
31 Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1993 1.89
32 Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation 1982 1.87
33 Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings. Circulation 1974 1.85
34 Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications. N Engl J Med 1966 1.83
35 Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol 1983 1.82
36 Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985 1.81
37 Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 1979 1.80
38 Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation. Am J Cardiol 1978 1.78
39 "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Am J Cardiol 1978 1.76
40 The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis 2000 1.66
41 Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation 1992 1.63
42 Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 1979 1.63
43 Relief of angina pectoris by electrical stimulation of the carotid-sinus nerves. N Engl J Med 1967 1.61
44 Limitations of the electrocardiographic response to exercise in predicting coronary-artery disease. N Engl J Med 1975 1.61
45 Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001 1.61
46 Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol 1987 1.57
47 Asymetric septal hypertrophy in childhood. Circulation 1976 1.56
48 Myocardial adenyl cyclase: activation by thyroid hormones and evidence for two adenyl cyclase systems. J Clin Invest 1969 1.56
49 Asymmetric septal hypertrophy (ASH): the unifying link in the IHSS disease spectrum. Observations regarding its pathogenesis, pathophysiology, and course. Circulation 1973 1.55
50 Role of increases in heart rate in determining the occurrence and frequency of myocardial ischemia during daily life in patients with stable coronary artery disease. J Am Coll Cardiol 1992 1.55
51 Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 1979 1.55
52 Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina. A clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation 1993 1.54
53 The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. Circulation 1984 1.54
54 Echocardiographic measurement of the left ventricular outflow gradient in idiopathic hypertrophic subaortic stenosis. N Engl J Med 1973 1.52
55 Prediction of the frequency and duration of ambulatory myocardial ischemia in patients with stable coronary artery disease by determination of the ischemic threshold from exercise testing: importance of the exercise protocol. J Am Coll Cardiol 1991 1.52
56 Exercise-induced ischemia in mildly symptomatic patients with coronary-artery disease and preserved left ventricular function. Identification of subgroups at risk of death during medical therapy. N Engl J Med 1984 1.51
57 Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res 1993 1.51
58 Sudden cardiac death without warning. Possible mechanisms and implications for screening asymptomatic populations. N Engl J Med 1989 1.50
59 Measurement of mitral orifice area in patients with mitral valve disease by real-time, two-dimensional echocardiography. Circulation 1975 1.49
60 Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol 2000 1.48
61 Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris. Am J Cardiol 1981 1.45
62 The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet 1996 1.44
63 Treatment of angina pectoris by electrical stimulation of the carotid-sinus nerves. N Engl J Med 1969 1.43
64 Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation 1979 1.42
65 Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet. Am J Cardiol 1980 1.42
66 Natural history of left ventricular function during 1 year after acute myocardial infarction: comparison with clinical, electrocardiographic and biochemical determinations. Am J Cardiol 1980 1.42
67 Angiogenic effects of low molecular weight heparin in patients with stable coronary artery disease: a pilot study. J Am Coll Cardiol 1993 1.42
68 Comparison of echocardiographic and necropsy measurements of ventricular wall thicknesses in patients with and without disproportionate septal thickening. Circulation 1977 1.41
69 Current concepts: evaluation of patients after acute myocardial infarction: indications for cardiac catheterization and surgical intervention. N Engl J Med 1982 1.41
70 Sensitivity, specificity and predictive accuracy of radionuclide cineangiography during exercise in patients with coronary artery disease. Comparison with exercise electrocardiography. Circulation 1979 1.40
71 Circulatory and symptomatic effects of physical training in patients with coronary-artery disease and angina pectoris. N Engl J Med 1972 1.40
72 Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation 1991 1.39
73 Circulatory effects of electrical stimulation of the carotid sinus nerves in man. Circulation 1969 1.38
74 Role of the capacitance and resistance vessels in vasovagal syncope. Circulation 1968 1.37
75 Coronary arterial-right heart fistulae. Long-term observations in seven patients. Circulation 1973 1.37
76 Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Proc Natl Acad Sci U S A 1993 1.35
77 Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy. Circulation 1981 1.35
78 Whither the ST segment during exercise. Circulation 1976 1.34
79 Sustained effects of nitroglycerin ointment in patients with angina pectoris. Circulation 1974 1.34
80 Electrical stability of acutely ischemic myocardium. Influences of heart rate and vagal stimulation. Circulation 1973 1.34
81 Activation of adenyl cyclase by glucagon in cat and human heart. Circ Res 1969 1.34
82 Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation 1978 1.33
83 Pathophysiological dilemma of syndrome X. Circulation 1992 1.32
84 Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988 1.31
85 Mechanism of left ventricular outlfow obstruction in patients with obstructive asymmetric septal hypertrophy (idiopathic hypertrophic subaortic stenosis). Am J Cardiol 1975 1.31
86 Medical management of patients with angina pectoris. Prog Cardiovasc Dis 1972 1.30
87 Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation 1981 1.30
88 In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci U S A 1994 1.29
89 Deterioration of myocardial function following aorto-coronary bypass operation. Circulation 1974 1.29
90 Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin. Circulation 1971 1.29
91 Effects of a reduction in environmental temperature on the circulatory response to exercise in man. Implications concerning angina pectoris. N Engl J Med 1969 1.29
92 Hemodynamic effects of diuresis at rest and during intense upright exercise in patients with impaired cardiac function. Circulation 1968 1.28
93 Effects of theophylline on myocardial mechanics. Am J Physiol 1972 1.28
94 Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 1996 1.28
95 Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 1994 1.27
96 Intraoperative coronary collateral function in patients with coronary occlusive disease. Nitroglycerin responsiveness and angiographic correlations. Circulation 1974 1.27
97 Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects. Circulation 1979 1.26
98 Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. Circulation 1979 1.25
99 Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice. Atherosclerosis 2001 1.25
100 Impairment of cardiac function in patients with pectus excavatum, with improvement after operative correction. N Engl J Med 1972 1.25
101 Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol 1999 1.25
102 Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 2001 1.24
103 Beneficial effects of vagal stimulation and bradycardia during experimental acute myocardial ischemia. Circulation 1974 1.24
104 Coronary artery occlusion in the conscious dog. Effects of alterations in arterial pressure produced by nitroglycerin, hemorrhage, and alpha-adrenergic agonists on the degree of myocardial ischemia. Circulation 1973 1.23
105 Observations on the optimum time for operative intervention for aortic regurgitation. I. Evaluation of the results of aortic valve replacement in symptomatic patients. Circulation 1980 1.22
106 Evaluation of the ability of echocardiography to measure acute alterations in left ventricular volume. Circulation 1974 1.21
107 Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve. Circulation 1985 1.21
108 Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ Res 1998 1.21
109 Uses and limitations of stress testing in the evaluation of ischemic heart disease. Circulation 1972 1.20
110 Effects of chronic right ventricular volume and pressure loading on left ventricular performance. Circulation 1971 1.19
111 Potential role of QT interval prolongation in sudden infant death syndrome. Circulation 1976 1.19
112 Effects of coronary-artery bypass on global and regional left ventricular function during exercise. N Engl J Med 1978 1.18
113 Physiological differences between the effects of neuronally released and bloodborne norepinephrine on beta adrenergic receptors in the arterial bed of the dog. Circ Res 1967 1.18
114 Cholinergic innervation of the canine and human ventricular conducting system. Anatomic and electrophysiologic correlations. Circulation 1974 1.18
115 Exercise-induced left ventricular dysfunction in symptomatic and asymptomatic patients with aortic regurgitation: assessment with radionuclide cineangiography. Am J Cardiol 1978 1.17
116 Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation 1992 1.17
117 Reduction of ischemic injury by nitroglycerin during acute myocardial infarction. N Engl J Med 1975 1.17
118 Asymmetric septal hypertrophy (ASH) in infancy. Circulation 1974 1.15
119 Acidic fibroblast growth factor in the developing rat embryo. J Cell Biol 1991 1.15
120 Atrioventricular valve replacement with the Hancock porcine xenograft: a five year clinical experience. Surgery 1975 1.15
121 The role of skin and muscle resistance vessels in reflexes mediated by the baroreceptor system. J Clin Invest 1970 1.15
122 Identification of congenital malformations of the great arteries in infants by real-time two-dimensional echocardiography. Circulation 1975 1.14
123 Congenitally bicuspid aortic valve causing severe, pure aortic regurgitation without superimposed infective endocarditis. Analysis of 13 patients requiring aortic valve replacement. Am J Cardiol 1981 1.13
124 Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Circulation 1993 1.13
125 Impairment of autonomically mediated heart rate control in patients with cardiac dysfunction. Circ Res 1975 1.13
126 Characterization of the circulatory response to maximal upright exercise in normal subjects and patients with heart disease. Circulation 1967 1.13
127 Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications. N Engl J Med 1966 1.13
128 Effect of nitroglycerin on exercise-induced abnormalities of left ventricular regional function and ejection fraction in coronary artery disease. Assessment by radionuclide clineagiography in symptomatic and asymptomatic patients. Circulation 1978 1.13
129 Implications of probability analysis on the strategy used for noninvasive detection of coronary artery disease. Role of single or combined use of exercise electrocardiographic testing, radionuclide cineangiography and myocardial perfusion imaging. Am J Cardiol 1980 1.13
130 Prevalence and characteristics of disproportionate ventricular septal thickening in patients with acquired or congenital heart diseases: echocardiographic and morphologic findings. Circulation 1977 1.12
131 Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 1978 1.12
132 Delivery strategies to achieve therapeutic myocardial angiogenesis. Circulation 2000 1.11
133 Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 1995 1.10
134 Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy. N Engl J Med 1989 1.10
135 Mechanism of action of epinephrine and glucagon on the canine heart. Evidence for increase in sarcotubular calcium stores mediated by cyclic 3',5'-AMP. Circ Res 1969 1.10
136 Observations on the optimum time for operative intervention for aortic regurgitation. II. Serial echocardiographic evaluation of asymptomatic patients. Circulation 1980 1.10
137 Tunnel subaortic stenosis: left ventricular outflow tract obstruction produced by fibromuscular tubular narrowing. Circulation 1976 1.10
138 Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation 1987 1.09
139 Aortic valve replacement in the elderly. Encouraging postoperative clinical and hemodynamic results. Arch Surg 1977 1.09
140 Echocardiographic observations in patients with systemic infiltrative disease involving the heart. Am J Cardiol 1977 1.09
141 Positive inotropic effects of dibutyryl cyclic adenosine 3',5'-monophosphate. Circ Res 1970 1.09
142 Blood fibrinolytic activity in man. Diurnal variation and the response to varying intensities of exercise. Circ Res 1970 1.08
143 Atherosclerosis in apoE knockout mice infected with multiple pathogens. J Infect Dis 2000 1.08
144 Acquired subvalvular right ventricular outflow obstruction in patients with ventricular septal defect. Am J Med 1972 1.07
145 Sudden death and the competitive athlete: perspectives on preparticipation screening studies. J Am Coll Cardiol 1986 1.07
146 Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function? N Engl J Med 1987 1.07
147 Reduction in myocardial ischemia with nitroglycerin or nitroglycerin plus phenylephrine administered during acute myocardial infarction. N Engl J Med 1975 1.06
148 Adenyl cyclase and cyclic AMP. Biochemical links in the regulation of myocardial contractility. Circulation 1971 1.06
149 The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF beta-receptor. Biochem Biophys Res Commun 1999 1.06
150 Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells. J Clin Invest 1997 1.06
151 Clinical and hemodynamic assessments of fabric-covered Starr-Edwards prosthetic valves. J Thorac Cardiovasc Surg 1970 1.06
152 Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. J Am Coll Cardiol 1990 1.05
153 Effects of calcium channel blocking agents on reperfusion arrhythmias. Am Heart J 1982 1.05
154 Creation of anastomoses between an extracardiac artery and the coronary circulation. Proof that myocardial angiogenesis occurs and can provide nutritional blood flow to the myocardium. Circulation 1990 1.05
155 Dynamic coronary tone in precipitation, exacerbation and relief of angina pectoris. Am J Cardiol 1981 1.05
156 Reversal of left ventricular dysfunction after aortic valve replacement for chronic aortic regurgitation: influence of duration of preoperative left ventricular dysfunction. Circulation 1984 1.04
157 Improved myocardial function during exercise after successful percutaneous transluminal coronary angioplasty. N Engl J Med 1982 1.04
158 Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. Circulation 1999 1.04
159 Myocardial infarction in young women with normal coronary arteriograms. Circulation 1971 1.03
160 Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ Res 1996 1.03
161 Aortic valve replacement without myocardial revascularization in patients with combined aortic valvular and coronary artery disease. Circulation 1981 1.03
162 Survival and functional results after valve replacement for aortic regurgitation from 1976 to 1983: impact of preoperative left ventricular function. Circulation 1985 1.02
163 Hemodynamic abnormalities in response to mild and intense upright exercise following operative correction of an atrial septal defect or tetralogy of Fallot. Circulation 1973 1.02
164 Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Echocardiographic and gross anatomic findings. Circulation 1974 1.02
165 Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 1993 1.02
166 Inhibition of the adrenergic nervous system in the treatment of angina pectoris. Med Clin North Am 1968 1.02
167 Left ventricular outflow tract obstruction due to systolic anterior motion of the anterior mitral leaflet in patients with concentric left ventricular hypertrophy. Circulation 1978 1.02
168 Results of valve replacement for severe mitral regurgitation due to papillary muscle rupture or fibrosis. Am J Cardiol 1973 1.02
169 Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy: efficacy of ventricular septal myotomy and myectomy. Eur Heart J 1983 1.01
170 Coronary artery occlusion in the conscious dog. Effects of alterations in heart rate and arterial pressure on the degree of myocardial ischemia. Circulation 1972 1.01
171 Coronary flow reserve, esophageal motility, and chest pain in patients with angiographically normal coronary arteries. Am J Med 1990 1.01
172 Reduction in severity and extent of myocardial infarction when nitroglycerin and methoxamine are administered during coronary occlusion. Circulation 1974 1.01
173 Current results of operation for mitral stenosis. Clinical and hemodynamic assessments in 124 consecutive patients treated by closed commissurotomy, open commissurotomy, or valve replacement. Circulation 1972 1.00
174 Echocardiographic abnormalities in chronic alcoholics with and without overt congestive heart failure. Am J Cardiol 1981 1.00
175 Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration. Am J Cardiol 1981 0.99
176 Hemodynamic accompaniments of angina: a comparison during angina induced by exercise and by atrial pacing. Circulation 1969 0.99
177 Studies on digitalis. XVII. Effects of ouabain on the hemodynamic response to exercise in patients with mitral stenosis in normal sinus rhythm. N Engl J Med 1968 0.99
178 Statistical correlation and heparin sensitivity of activated partial thromboplastin time, whole blood coagulation time, and an automated coagulation time. Am J Clin Pathol 1973 0.99
179 Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease: sex-based differences in inflammation and type of immune response. Circulation 2000 0.98
180 Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis. Br Heart J 1970 0.98
181 Adenyl cyclase and myocardial contractility. Ann Intern Med 1970 0.98
182 Determinants of ventricular septal motion. Influence of relative right and left ventricular size. Circulation 1976 0.98
183 Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. Am J Cardiol 1985 0.98
184 Indices predicting long-term survival after valve replacement in patients with aortic regurgitation and patients with aortic stenosis. Circulation 1974 0.98
185 Dynamic subaortic obstruction in hypertrophic cardiomyopathy: analysis by pulsed Doppler echocardiography. J Am Coll Cardiol 1985 0.98
186 Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. J Am Coll Cardiol 1989 0.98
187 Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 1987 0.97
188 Congenital heart malformations associated with disproportionate ventricular septal thickening. Circulation 1975 0.97
189 Biventricular cineangiography in the evaluation of patients with asymmetric septal hypertrophy. Circulation 1974 0.97
190 Comparison of the peak inotropic effects of a catecholamine and a digitalis glycoside in the intact canine heart. Circulation 1970 0.97
191 Hemodynamic principles in the control of coronary blood flow. Am J Cardiol 1985 0.97
192 Left ventricular function at rest and during exercise after aortic valve replacement in patients with aortic regurgitation. Am J Cardiol 1979 0.96
193 Improved left ventricular diastolic filling in patients with coronary artery disease after percutaneous transluminal coronary angioplasty. Circulation 1982 0.96
194 Influence of pericardiectomy on cat right ventricular function after pulmonary arterial constriction. Am J Cardiol 1973 0.96
195 Influence of hyperthyroidism on the effects of norepinephrine on myocardial adenyl cyclase activity and contractile state. Endocrinology 1969 0.96
196 NIH clinical staff conference. Assessment of cardiac function. Ann Intern Med 1969 0.96
197 Influence of extracellular potassium concentration on myocardial uptake and inotropic effect of tritiated digoxin. Circ Res 1971 0.96
198 Hypertrophic cardiomyopathy with unusual locations of left ventricular hypertrophy undetectable by M-mode echocardiography. Identification by wide-angle two-dimensional echocardiography. Circulation 1981 0.95
199 Influence of sulfinpyrazone and naproxen on infarct size in the dog. Am J Cardiol 1981 0.95
200 Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy). Am J Cardiol 1982 0.95
201 Reflex cardiovascular depression produced by stimulation of pulmonary stretch receptors in the dog. J Clin Invest 1969 0.95
202 Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy. J Am Coll Cardiol 1986 0.95
203 Hypertrophic cardiomyopathy: a common cause of sudden death in the young competitive athlete. Eur Heart J 1983 0.94
204 Effects of experimental heart failure on the capacity of glucagon to augment myocardial contractility and activate adenyl cyclase. J Clin Invest 1970 0.94
205 Postoperative assessment of patients with ventricular septal defect and pulmonary hypertension. Response to intense upright exercise. Circulation 1973 0.94
206 Clinical and hemodynamic appraisal of beta adrenergic blocking drugs. Ann N Y Acad Sci 1967 0.94
207 Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy. Am J Cardiol 1991 0.93
208 The natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function. Circulation 1983 0.93
209 The case for preoperative coronary angiography in patients with tetralogy of Fallot and other complex congenital heart diseases. Am Heart J 1982 0.93
210 Alterations in the circulatory response to exercise following a meal and their relationship to postprandial angina pectoris. Circulation 1971 0.93
211 Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant response. Int Immunol 2001 0.93
212 Decreased myocardial adenyl cyclase activity in hypothyroidism. J Clin Invest 1969 0.93
213 Influence of atropine and of vagally mediated bradycardia on the occurrence of ventricular arrhythmias following acute coronary occlusion in closed-chest dogs. Circulation 1973 0.93
214 Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ Res 1991 0.93
215 Preoperative exercise capacity in symptomatic patients with aortic regurgitation as a predictor of postoperative left ventricular function and long-term prognosis. Circulation 1980 0.93
216 Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. Am J Cardiol 2000 0.93
217 Long-term anatomic fate of coronary-artery bypass grafts and functional status of patients five years after operation. N Engl J Med 1978 0.93
218 Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. Circulation 1989 0.93
219 Interaction of human cytomegalovirus with p53: possible role in coronary restenosis. Scand J Infect Dis Suppl 1995 0.92
220 Three year anatomic, functional and clinical follow-up after successful percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1987 0.92
221 The effect of beta adrenergic blockade on patterns of urinary sodium excretion. Studies in normal subjects and in patients with heart disease. Ann Intern Med 1966 0.92
222 Chest wall syndrome. A common cause of unexplained cardiac pain. JAMA 1979 0.92
223 Inhibition of smooth muscle cell proliferation by an antisense oligodeoxynucleotide targeting the messenger RNA encoding proliferating cell nuclear antigen. Circulation 1992 0.92
224 A model to assess interventions to improve collateral blood flow: continuous administration of agents into the left coronary artery in dogs. Cardiovasc Res 1993 0.92
225 Combined mitral and aortic regurgitation in ankylosing spondylitis. Angiographic and anatomic features. Am J Med 1974 0.92
226 Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction. Circulation 1987 0.91
227 Impaired fibrinolytic response to exercise in patients with type-IV hyperlipoproteinaemia. Lancet 1970 0.91
228 Site of increased resistance to coronary flow in patients with angina pectoris and normal epicardial coronary arteries. J Am Coll Cardiol 1986 0.91
229 Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation 1999 0.91
230 Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models. J Am Coll Cardiol 2000 0.91
231 Accumulation of gallium-67 in regions of acute myocardial infarction. Am J Cardiol 1974 0.91
232 Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy. Am J Cardiol 1985 0.91
233 Lack of effect of aspirin on myocardial infarct size in the dog. Am J Cardiol 1981 0.90
234 Regional contractility. Selective depression of ischemic myocardium by verapamil. Circulation 1976 0.90
235 Calcium in the aortic valve. Roentgenologic and hemodynamic correlations in 148 patients. Ann Intern Med 1969 0.90
236 Mechanisms of reflex vasodilation: assessment of the role of neural reuptake of norepinephrine and release of histamine. J Clin Invest 1968 0.90
237 Prevalence and persistence of antibodies to herpes viruses, Chlamydia pneumoniae and Helicobacter pylori in Alaskan Eskimos: the GOCADAN Study. Clin Microbiol Infect 2006 0.90
238 Effects of ouabain on the left ventricular response to exercise in patients with angina pectoris. Circulation 1971 0.89
239 Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs. J Am Coll Cardiol 2000 0.89
240 Monocytes harboring cytomegalovirus: interactions with endothelial cells, smooth muscle cells, and oxidized low-density lipoprotein. Possible mechanisms for activating virus delivered by monocytes to sites of vascular injury. Circ Res 1997 0.89
241 Demonstration of adenyl cyclase activity in canine cardiac sarcoplasmic reticulum. Biochem Biophys Res Commun 1969 0.89
242 Serum of cytomegalovirus-infected mice induces monocyte chemoattractant protein-1 expression by endothelial cells. J Infect Dis 2001 0.89
243 Timing of operation for chronic aortic regurgitation. Am J Cardiol 1982 0.89
244 Evaluation of aortic valve replacement in patients with valvular aortic stenosis. Circulation 1980 0.89
245 Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone. Am J Cardiol 1991 0.89
246 Effects of chronic heart failure on the capacity of glucagon to enhance contractility and adenyl cyclase activity of human papillary muscles. Circulation 1971 0.88
247 Immunohistochemical localization of basic and acidic fibroblast growth factors in the developing rat heart. Circulation 1991 0.88
248 Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise. Circulation 1982 0.88
249 Transforming growth factor-beta 1 in normal heart and in myocardial infarction. Ann N Y Acad Sci 1990 0.88
250 Dose-dependent smooth muscle cell proliferation induced by thermal injury with pulsed infrared lasers. Circulation 1992 0.88
251 Beneficial effect of lidocaine on ventricular electrical stability and spontaneous ventricular fibrillation during experimental myocardial infarction. Am J Cardiol 1976 0.88
252 Prognostic implications of myocardial ischemia during daily life in low risk patients with coronary artery disease. J Am Coll Cardiol 1993 0.88
253 Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest. Am J Cardiol 1991 0.87
254 Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J Clin Invest 1996 0.87
255 Strategy for evaluation and surgical treatment of the asymptomatic or mildly symptomatic patient with coronary artery disease. Am J Cardiol 1979 0.87
256 Limitations of electrocardiographic exercise testing. N Engl J Med 1979 0.87
257 Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1989 0.87
258 Nitroglycerin-induced improvement in exercise tolerance and hemodynamics in patients with chronic rheumatic heart valve disease. Am J Cardiol 1978 0.87
259 Evaluation of the acute and chronic safety of the biosense injection catheter system in porcine hearts. Catheter Cardiovasc Interv 1999 0.87
260 Nitroglycerin-induced reduction in the incidence of spontaneous ventricular fibrillation during coronary occlusion in dogs. Am J Cardiol 1974 0.87
261 Influence of extracellular magnesium on capillary endothelial cell proliferation and migration. Circ Res 1990 0.86
262 Beneficial electrophysiologic effects of nitroglycerin during acute myocardial infarction. Am J Cardiol 1974 0.86
263 16th Bethesda Conference: Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. October 3-5, 1984. J Am Coll Cardiol 1985 0.86
264 Alterations of fibrinolysis and blood coagulation induced by exercise, and the role of beta-adrenergic-receptor stimulation. Lancet 1968 0.86
265 Prognosis of asymptomatic or mildly symptomatic patients with coronary artery disease. Am J Cardiol 1982 0.86
266 Value and limitations of the electrocardiographic response to exercise in the assessment of patients with coronary artery disease. Controversies in cardiology--II. Am J Cardiol 1978 0.86
267 Rabbit ear model of injury-induced arterial smooth muscle cell proliferation. Kinetics, reproducibility, and implications. Circ Res 1991 0.85
268 Abnormal right ventricular size and ventricular septal motion after atrial septal defect closure: etiology and functional significance. Am J Cardiol 1978 0.85
269 Bradycardia and its complications in the prehospital phase of acute myocardial infarction. Am J Cardiol 1973 0.85
270 Morphologic evidence for "small vessel disease" in patients with hypertrophic cardiomyopathy. Z Kardiol 1987 0.85
271 Do antisense approaches to the problem of restenosis make sense? Circulation 1993 0.84
272 The dynamic nature of left ventricular outflow obstruction in idiopathic hypertrophic subaortic stenosis. Ann Intern Med 1971 0.84
273 Relation between marked changes in left ventricular outflow tract gradient and disease progression in hypertrophic cardiomyopathy. Am J Cardiol 1984 0.84
274 Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain. J Am Coll Cardiol 1987 0.83
275 Gene therapy for vascular disease. FASEB J 1995 0.83
276 Editorial: The role of operative treatment in patients with idiopathic hypertrophic subaortic stenosis. Circulation 1973 0.83
277 Chest pain and "normal" coronary arteries--role of small coronary arteries. Am J Cardiol 1985 0.83
278 Transmural myocardial infarction in hypertrophic cardiomyopathy: a cause of conversion from left ventricular asymmetry to symmetry and from normal-sized to dilated left ventricular cavity. Chest 1981 0.83
279 Beneficial and detrimental effects of lidoflazine in microvascular angina. Am J Cardiol 1990 0.83
280 Effects of nitroglycerin and nitroglycerin-methoxamine during acute myocardial ischemia in dogs with pre-existing multivessel coronary occlusive disease. Circulation 1975 0.83
281 Acute coronary occlusion: prolonged increase in collateral flow following brief administration of nitroglycerin and methoxamine. Am J Cardiol 1977 0.83
282 Determinants of arrhythmic death due to coronary spasm: effect of preexisting coronary artery stenosis on the incidence of reperfusion arrhythmia. Circulation 1982 0.82
283 Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy. Circulation 1989 0.82
284 Exercise performance after septal myotomy and myectomy in patients with obstructive hypertrophic cardiomyopathy. Am J Cardiol 1979 0.82
285 Prolapse of the mitral valve is described in two patients with the Ebstein's anomaly of the tricuspid. Am J Cardiol 1976 0.82
286 Sulfinpyrazone and aspirin increase epicardial coronary collateral flow in dogs. Am J Cardiol 1981 0.82
287 Exercise in patients with heart disease. Effects of body position and type and intensity of exercise. Am J Cardiol 1969 0.82
288 Heparin promotes the formation of extracardiac to coronary anastomoses in a canine model. Am J Physiol 1991 0.82
289 Disproportionate ventricular thickening in patients with systemic hypertension. Chest 1978 0.82
290 Mitral valve replacement in elderly patients: encouraging postoperative clinical and hemodynamic results. J Thorac Cardiovasc Surg 1979 0.82
291 Nongenetically transmitted disproportionate ventricular septal thickening associated with left ventricular outflow obstruction. Br Heart J 1979 0.82
292 Comparison of nitroglycerin-, nitroprusside-, and phentolamine-induced changes in coronary collateral function in dogs. J Clin Invest 1977 0.82
293 Circadian variation in ischemic threshold. A mechanism underlying the circadian variation in ischemic events. Circulation 1992 0.81
294 Lack of association of restenosis following coronary angioplasty with elevated C-reactive protein levels or seropositivity to Chlamydia pneumoniae. Am J Cardiol 1999 0.81
295 Effects of intracoronary and intravenous nitroglycerin on coronary collateral function. J Pharmacol Exp Ther 1976 0.81
296 Activation of cardiac adenyl cyclase by thyroid hormone. Biochem Biophys Res Commun 1968 0.81
297 Results of operation for obstructive hypertrophic cardiomyopathy in the elderly. Septal myotomy and myectomy in 20 patients 65 years of age or older. Am J Cardiol 1980 0.81
298 Impairment of the diurnal fibrinolytic response in man. Effects of aging, type IV hyperlipoproteinemia, and coronary artery disease. Circ Res 1973 0.81
299 Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation. Circulation 1988 0.81
300 Differential diagnosis of type and severity of obstruction to left ventricular outflow. Prog Cardiovasc Dis 1971 0.81
301 Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: implications regarding therapy. Am J Cardiol 1984 0.81
302 Chlamydia pneumoniae-induced transactivation of the major immediate early promoter of cytomegalovirus: potential synergy of infectious agents in the pathogenesis of atherosclerosis. J Infect Dis 2000 0.80
303 Loss of microspheres from ischemic canine cardiac tissue: an important technical limitation. Circ Res 1979 0.80
304 Prevalence and characteristics of disporportionate ventricular septal thickening in infants with congenital heart disease. Circulation 1979 0.80
305 Editorial: Nitrates in the prophylactic treatment of angina pectoris. Circulation 1973 0.80
306 Atropine and acute myocardial infarction. Circulation 1972 0.80
307 Extracardiac to coronary anastomoses support regional left ventricular function in dogs. Am J Physiol 1993 0.80
308 Potentiation of the inotropic effects of norepinephrine and dibutyryl cyclic AMP by theophylline. J Mol Cell Cardiol 1971 0.80
309 Heparin-binding transforming growth factor alpha-Pseudomonas exotoxin A. A heparan sulfate-modulated recombinant toxin cytotoxic to cancer cells and proliferating smooth muscle cells. J Biol Chem 1993 0.80
310 Airway hyperresponsiveness in patients with microvascular angina. Evidence for a diffuse disorder of smooth muscle responsiveness. Circulation 1990 0.80
311 The effects of synchronized counterpulsation of the pulmonary artery on right ventricular hemodynamics. J Thorac Cardiovasc Surg 1971 0.80
312 Neural basis for the genesis and control of arrhythmias associated with myocardial infarction. Cardiology 1976 0.80
313 Incidence, nature, and etiology of metabolic alkalosis in dogs and cats. J Vet Intern Med 2013 0.80
314 Reliability of assessing change with sequential coronary angiography. Am Heart J 1982 0.79
315 Mitral restenosis: an uncommon cause of recurrent symptoms following mitral commissurotomy. Am J Cardiol 1970 0.79
316 The use of indirect indices of myocardial oxygen consumption in evaluating angina pectoris. Chest 1973 0.79
317 Hemodynamic function of the Kay-Shiley prosthetic cardiac valve. Observations after mitral or tricuspid valve replacement. Chest 1973 0.79
318 Verapamil therapy: a new approach to pharmacologic treatment of hypertrophic cardiomyopathy. Chest 1980 0.79
319 Successful operative correction of intrapulmonary rupture of a post-traumatic left ventricular aneurysm. Documentation of complete spontaneous closure of an associated ventricular septal defect. Am J Cardiol 1972 0.79
320 Mechanism of the sympathomimetic action of cyclohexylamine and hexylamine: release of catecholamines from nerve endings. J Pharmacol Exp Ther 1969 0.79
321 Coronary calcifications in the detection of coronary artery disease and comparison with electrocardiographic exercise testing. Results from the National Heart, Lung, and Blood Institute's type II coronary intervention study. Circulation 1979 0.79
322 Prognostic implications of symptomatic versus asymptomatic (silent) myocardial ischemia induced by exercise in mildly symptomatic and in asymptomatic patients with angiographically documented coronary artery disease. Am J Cardiol 1987 0.79
323 Relative effects of sulfinpyrazone and ibuprofen on canine platelet function and prostaglandin-mediated coronary vasodilation. J Cardiovasc Pharmacol 1980 0.79
324 Saphenous vein bypass grafts: Long-term patency and effect on the native coronary circulation. Am J Cardiol 1975 0.79
325 Relation between exertional ischemia and prognosis in mildly symptomatic patients with single or double vessel coronary artery disease and left ventricular dysfunction at rest. J Am Coll Cardiol 1989 0.79
326 Marfan cardiovascular disease without the Marfan syndrome. Fusiform ascending aortic aneurysm with aortic and mitral valve regurgitation. Chest 1980 0.78
327 Computer-based analysis of preoperative and postoperative prognostic factors in 100 patients with combined aortic and mitral valve replacement. Circulation 1973 0.78
328 Beneficial effect of physical training on blood flow to myocardium perfused by chronic collaterals in the exercising dog. Circulation 1978 0.78
329 Carotid sinus nerve stimulation for the treatment of intractable angina pectoris: surgical technic. Ann Surg 1970 0.78
330 Left ventricular myotomy and myectomy in patients with obstructive hypertrophic cardiomyopathy and previous cardiac arrest. Am J Cardiol 1980 0.78
331 Long-term hemodynamic and electrocardiographic assessment following operative repair of tetralogy of Fallot. Circulation 1978 0.78
332 Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension. S Afr Med J 1977 0.78
333 Correlation of antiarrhythmic effects of diphenylhydantoin with digoxin-induced changes in myocardial contractility, sodium-potassium adenosine triphosphatase activity, and potassium efflux. Circ Res 1973 0.78
334 Sudden death and hypertrophic cardiomyopathy. Am Heart J 1985 0.78
335 Effect of septal myotomy and myectomy on left ventricular systolic function at rest and during exercise in patients with IHSS. Circulation 1979 0.78
336 Potentiation of the contractile effects of norepinephrine by hypoxia. J Clin Invest 1972 0.78
337 Potentiation of the inotropic effects of glucagon by theophylline. J Pharmacol Exp Ther 1971 0.78
338 Contractile damage from reperfusion after transient ischemia in the dog. J Thorac Cardiovasc Surg 1978 0.78
339 Comparative effects of verapamil, diltiazem, and nifedipine on hemodynamics and left ventricular function during acute myocardial ischemia in dogs. Circulation 1984 0.78
340 Medical and surgical therapy of hypertrophic cardiomyopathy. Cardiovasc Clin 1988 0.78
341 Comparison of relative inotropic and chronotropic effects of propranolol, practolol, and sotalol. Chest 1973 0.77
342 Could plasmid-mediated gene transfer into the myocardium be augmented by left ventricular guided laser myocardial injury? Catheter Cardiovasc Interv 2001 0.77
343 Comparison of exercise testing with studies of coronary flow reserve in patients with microvascular angina. Circulation 1991 0.77
344 Platelet hyperaggregability across the coronary bed in response to rapid atrial pacing in patients with stable coronary artery disease. Circulation 1992 0.77
345 In vitro effects of a recombinant toxin targeted to the fibroblast growth factor receptor on rat vascular smooth muscle and endothelial cells. Circ Res 1992 0.77
346 Controlling collateral development: the difficult task of mimicking mother nature. Cardiovasc Res 2001 0.77
347 Prevalence of autoantibodies against contractile proteins in coronary artery disease and their clinical implications. Am J Cardiol 2000 0.77
348 Chronic non-vascular cytomegalovirus infection: effects on the neointimal response to experimental vascular injury. Cardiovasc Res 2000 0.77
349 Electrocardiographic evidence of left ventricular hypertrophy in otherwise normal children. Clarification by echocardiography. Am J Cardiol 1975 0.77
350 Cost-effective application of the Centers for Disease Control Guideline for Prevention of Catheter-associated Urinary Tract Infections. Am J Infect Control 1985 0.77
351 Determinants of ventricular arrhythmias in mildly symptomatic patients with coronary artery disease and influence of inducible left ventricular dysfunction on arrhythmia frequency. J Am Coll Cardiol 1987 0.77
352 Hypotension, nitroglycerin, and acute myocardial infarction. Circulation 1973 0.76
353 Enhancement of electrical stability of acutely ischemic myocardium by edrophonium. Circulation 1974 0.76
354 Traumatic coronary arteriovenous fistula. A 20 year follow-up with seria hemodynamic and angiographic studies. Am J Cardiol 1971 0.76
355 Role of cellular proteinases in acute myocardial infarction. I. Proteolysis in nonischemic and ischemic rat myocardium and the effects of antipain, leupeptin, pepstatin and chymostatin administered in vivo. J Am Coll Cardiol 1983 0.76
356 Prevalence and characteristics of disproportionate ventricular septal thickening in patients with coronary artery disease. Circulation 1978 0.76
357 Dynamic obstruction to left ventricular outflow: the case for its existence in hypertrophic cardiomyopathy. Z Kardiol 1987 0.76
358 Hypertrophic cardiomyopathy: the great masquerader. Clinical conference from the Cardiology Branch of the National Heart, Lung, and Blood Institute, Bethesda, Md. Chest 1978 0.76
359 Experimental acute myocardial infarction. Characterization and treatment of the malignant premature ventricular contraction. Circulation 1973 0.76
360 Inhibition of vascular smooth muscle cell proliferation and neointimal accumulation by adenovirus-mediated gene transfer of cytosine deaminase. Circulation 1997 0.76
361 A discussion on hypertrophic cardiomyopathy. Am Heart J 1978 0.76
362 Relative effects of aspirin on platelet aggregation and prostaglandin-mediated coronary vasodilatation in the dog. Circulation 1980 0.76
363 Idiopathic left ventricular hypertrophy. N Engl J Med 1974 0.76
364 Relative effects of nitroglycerin and nitroprusside during experimental acute myocardial ischemia. Eur J Cardiol 1980 0.76
365 Indications for coronary artery bypass surgery in patients with chronic angina pectoris: implications of the multicenter randomized trials. Circulation 1985 0.76
366 VT and sudden death in HCM patients. Circulation 1989 0.75
367 Long-term variation in myocardial ischemia during daily life in patients with stable coronary artery disease: its relation to changes in the ischemic threshold. J Am Coll Cardiol 1992 0.75
368 National Heart, Lung, and Blood Institute type II Coronary Intervention Study: design, methods, and baseline characteristics. Control Clin Trials 1982 0.75
369 Catheter-based plasmid-mediated transfer of genes into ischemic myocardium using the pCOR plasmid. Coron Artery Dis 2000 0.75
370 Idiopathic hypertrophic subaortic stenosis with and without mitral regurgitation. Phonocardiographic differentiation from rheumatic mitral regurgitation. Br Heart J 1972 0.75
371 Cytotoxic effects of vascular smooth muscle cells of the chimeric toxin, heparin binding TGF alpha-Pseudomonas exotoxin. Cardiovasc Res 1993 0.75
372 Long-term hemodynamic assessment of the porcine heterograft in the mitral position. Late development of valvular stenosis. Circulation 1981 0.75
373 Effects of hepatitis A vaccination on atherogenesis in a murine model. J Viral Hepat 2003 0.75
374 Association of secundum atrial septal defect and atrioventricular nodal dysfunction. A genetically transmitted syndrome. Br Heart J 1978 0.75
375 Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris. Am J Cardiol 1985 0.75
376 Diagnostic yield of cytologic analysis of pericardial effusion in dogs. J Vet Intern Med 2013 0.75
377 Coronary collateral function in patients without occlusive coronary artery disease. Circulation 1975 0.75
378 Atropine and acute myocardial infarction. Reply. Circulation 1973 0.75
379 Hemodynamic studies in patients with 2M and 3M Starr-Edwards Prostheses: evidence of obstruction to left atrial emptying. Circulation 1969 0.75
380 Importance of identifying left main coronary artery narrowing in subsets of patients with coronary artery disease. Ann Intern Med 1979 0.75
381 Myocardial proteolysis during acute myocardial ischaemia. Cardiovasc Res 1983 0.75
382 Clinical applications of inhibition of beta-adrenergic receptors with Propranolol. Med Ann Dist Columbia 1969 0.75
383 Effects of operation on left atrial size and the occurence of atrial fibrillation in patients with hypertrophic subaortic stenosis. Circulation 1977 0.75
384 Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy. Circulation 1985 0.75
385 Aspirin-induced increase in collateral flow after acute coronary occlusion in dogs. Circulation 1979 0.75
386 Lack of correlation between angiographic grading of collateral and myocardial perfusion and function: implications for the assessment of angiogenic response. Coron Artery Dis 2001 0.75
387 Is preoperative left ventricular function predictive of survival and functional results after aortic valve replacement for chronic aortic regurgitation? J Am Coll Cardiol 1987 0.75
388 Hypotension and carotid-sinus-nerve stimulation. N Engl J Med 1969 0.75
389 Prevalence and significance of an abnormal S-T segment response to exercise in a young athletic population. Am J Cardiol 1983 0.75
390 Clinical applications of inhibition of beta-adrenergic receptors with propranolol. J Med Assoc Ga 1969 0.75
391 Left ventricular function in mitral valve prolapse: assessment with radionuclide cineangiography. Am J Cardiol 1981 0.75
392 Comparative effects of calcium-channel blocking agents on left ventricular function during acute ischemia in dogs with and without congestive heart failure. Am J Cardiol 1985 0.75
393 Mechanism of elevated innominate artery pressures in supravalvular aortic stenosis. Circulation 1970 0.75
394 Letter: Does pectus excavatum cause functional disability? J Thorac Cardiovasc Surg 1976 0.75
395 Relationship between regional contractile function and S-T segment elevation after experimental coronary artery occlusion in the dog. Cardiovasc Res 1978 0.75
396 Determinants of arrhythmic death during coronary artery reperfusion: effect of perfusion bed size. Am Heart J 1983 0.75
397 Effects of psychopharmacologic agents on myocardial contractility. J Pharmacol Exp Ther 1970 0.75
398 Blood flow to infarct and surviving myocardium: implications regarding the action of verapamil on the acutely ischemic dog heart. J Am Coll Cardiol 1984 0.75
399 The acute and chronic effects of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy. Eur Heart J 1983 0.75
400 Pathophysiology of asymmetric septal hypertrophy. Ann Radiol (Paris) 1977 0.75
401 Influence of needle gauge used for venipuncture on automated platelet count and coagulation profile in dogs. Aust Vet J 2014 0.75
402 Current status of the Starr-Edwards cloth-covered prosthetic cardiac valves. Circulation 1972 0.75
403 Verapamil in the treatment of hypertrophic cardiomyopathy. Ann Intern Med 1982 0.75
404 Apoptosis in vascular disease: opportunities for genetic therapeutic intervention. Semin Interv Cardiol 1996 0.75
405 Postperfusion nonthrombocytopenic purpura. An uncommon sequel of open heart surgery. Am J Cardiol 1968 0.75
406 Creatinine excretion. Lancet 1970 0.75
407 Protection of ischemic myocardium by nitroglycerin: experimental and clinical results. Circulation 1976 0.75
408 Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog. J Pharmacol Exp Ther 1989 0.75
409 Role of cellular proteinases in acute myocardial infarction. II. Influence of in vivo suppression of myocardial proteolysis by antipain, leupeptin and pepstatin on myocardial infarct size in the rat. J Am Coll Cardiol 1983 0.75
410 Clinical applications of inhibition of beta-adrenergic receptors with propranolol. S D J Med 1969 0.75
411 Hypertrophic cardiomyopathy: an overview. Clin Invest Med 1980 0.75
412 Vasodilators in the management of acute myocardial infarction. Adv Cardiol 1978 0.75
413 Clinical course of patients with hypertrophic cardiomyopathy. Cardiovasc Clin 1979 0.75
414 Clinical uses of inhibition of beta-adrenergic receptors with propranolol. Calif Med 1969 0.75
415 Clinical significance and therapeutic implications of the left ventricular outflow tract pressure gradient in hypertrophic cardiomyopathy. Am J Cardiol 1986 0.75
416 A flow-through sample holder for the Coulter Counter. Tech Bull Regist Med Technol 1967 0.75
417 Effects of glucagon on adenyl cyclase activity in the left and right ventricles and liver in experimentally-produced isolated right ventricular failure. J Mol Cell Cardiol 1970 0.75
418 Effect of verapamil on pH of ischemic canine myocardium. J Am Coll Cardiol 1985 0.75
419 Pathophysiology and experimental treatment of acute pulmonary embolism. Am Heart J 1971 0.75
420 Ralstonia pickettii septicemia in a dog with immune-mediated thrombocytopenia. J Vet Intern Med 2009 0.75
421 Sudden infant death syndrome (SIDS). Echocardiographic studies in relatives of infants with SIDS. J Clin Ultrasound 1977 0.75
422 Secondary prevention and lipid lowering: results and implications. Am Heart J 1985 0.75
423 Effect of reserpine on the increase in myocardial adenyl cyclase activity produced by thyroid hormone. Proc Soc Exp Biol Med 1971 0.75
424 Diagnostic use of exercise stress testing. N Engl J Med 1979 0.75
425 Lack of association of infectious agents with risk of future myocardial infarction and stroke: definitive evidence disproving the infection/coronary artery disease hypothesis? Circulation 1999 0.75
426 Dynamic coronary obstruction as a cause of angina pectoris: implications regarding therapy. Am J Cardiol 1985 0.75
427 Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force V: Ischemic heart disease. J Am Coll Cardiol 1985 0.75
428 Alterations in regional contractility following cardiopulmonary bypass with intraoperative ischemia. J Thorac Cardiovasc Surg 1978 0.75
429 Clinical and hemodynamic results following triple valve replacement: mechanical vs porcine xenograft prostheses. Circulation 1977 0.75
430 "Losing the war against cancer". New Solut 1992 0.75
431 Letter: Treatment of angina pectoris. Circulation 1974 0.75
432 Clinical applications of inhibition of beta-adrenergic receptors with propranolol. Md State Med J 1969 0.75
433 Long-term postoperative prognosis of patients with congenital heart disease. Clinical conference from the Cardiology Branch of the National Heart, Lung, and Blood Institute. Chest 1977 0.75
434 Whither the ST segment during exercise? Adv Cardiol 1978 0.75
435 Clinical applications for the inhibition of beta-adrenergic receptors with propranolol. J Iowa Med Soc 1969 0.75
436 Incidence, nature, and etiology of metabolic acidosis in dogs and cats. J Vet Intern Med 2012 0.75
437 Comparative accuracy of several published formulae for the estimation of serum osmolality in cats. J Small Anim Pract 2013 0.75
438 Obstructive hypertrophic cardiomyopathy associated with minimal left ventricular hypertrophy. Am J Cardiol 1984 0.75
439 Effects of ouabain on the left ventricular response to atrial pacing in patients with angina pectoris. Am J Cardiol 1971 0.75
440 Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. Clin Invest Med 1980 0.75
441 Calcium carbonate as a phosphate binder. One year's experience. ASAIO Trans 1987 0.75
442 Non-invasive detection and evaluation of the functional severity of coronary artery disease: the role of radionuclide cineangiography during exercise. Acta Med Scand Suppl 1978 0.75
443 The effects of nitroglycerin-methoxamine combination on infarct size in conscious dogs. Am Heart J 1983 0.75
444 Clinical applications of inhibition of beta-adrenergic receptors with propranolol. J S C Med Assoc 1969 0.75
445 The fibrinolytic response of man to vasoactive drugs measured in arterial blood. Thromb Res 1978 0.75
446 Complications of carotid-sinus stimulation. N Engl J Med 1969 0.75
447 Low density lipoprotein modulation of porcine coronary artery contractile response to histamine. Atherosclerosis 1987 0.75